Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Hall

Showing results (141-150 of 225) with videos related to

Pageof 23
Sort By:
Clinical and Translational Radiation Oncology|February 20, 2020
Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trialJulia Murray, Sarah Gulliford, Clare Griffin, et al.
Research Involvement and Engagement|July 2, 2025
Patient and public involvement in the SPRUCE methodology study investigating electronic patient reported outcomes in oncology clinical trialsMorgaine Stiles, Monisha Dewan, Georgina Manning, et al.
British Journal of Cancer|October 21, 2021
VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penisSteve Nicholson, Holly Tovey, Tony Elliott, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 27, 2019
A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancerJulia Murray, Clare Griffin, Sarah Gulliford, et al.
European Urology|October 4, 2018
BOXIT-A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004)John D Kelly, Wei Shen Tan, Nuria Porta, et al.
European Urology Focus|July 30, 2017
Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional SurveyDavid Lorente, Praful Ravi, Niven Mehra, et al.
Frontiers in Oncology|August 12, 2025
Radiation-induced extracellular matrix remodelling drives prognosis and predicts radiotherapy response in muscle-invasive bladder cancerConrado Guerrero Quiles, Siobhan Fahy, Matej Bartak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2024
Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT TrialAlison Jane Birtle, Robert Jones, John Chester, et al.
The Lancet. Oncology|July 9, 2023
Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trialChristopher Nutting, Laura Finneran, Justin Roe, et al.
International Journal of Radiation Oncology, Biology, Physics|December 12, 2018
Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)David Dearnaley, Clare L Griffin, Rebecca Lewis, et al.
Pageof 23

Showing results (141-150 of 225) with videos related to

Sort By:
Pageof 23
Clinical and Translational Radiation Oncology|February 20, 2020
Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trialJulia Murray, Sarah Gulliford, Clare Griffin, et al.
Research Involvement and Engagement|July 2, 2025
Patient and public involvement in the SPRUCE methodology study investigating electronic patient reported outcomes in oncology clinical trialsMorgaine Stiles, Monisha Dewan, Georgina Manning, et al.
British Journal of Cancer|October 21, 2021
VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penisSteve Nicholson, Holly Tovey, Tony Elliott, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 27, 2019
A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancerJulia Murray, Clare Griffin, Sarah Gulliford, et al.
European Urology|October 4, 2018
BOXIT-A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004)John D Kelly, Wei Shen Tan, Nuria Porta, et al.
European Urology Focus|July 30, 2017
Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional SurveyDavid Lorente, Praful Ravi, Niven Mehra, et al.
Frontiers in Oncology|August 12, 2025
Radiation-induced extracellular matrix remodelling drives prognosis and predicts radiotherapy response in muscle-invasive bladder cancerConrado Guerrero Quiles, Siobhan Fahy, Matej Bartak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2024
Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT TrialAlison Jane Birtle, Robert Jones, John Chester, et al.
The Lancet. Oncology|July 9, 2023
Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trialChristopher Nutting, Laura Finneran, Justin Roe, et al.
International Journal of Radiation Oncology, Biology, Physics|December 12, 2018
Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)David Dearnaley, Clare L Griffin, Rebecca Lewis, et al.
Pageof 23